Walleye Capital
VECT

Walleye Capital’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Walleye Capital’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-104,819
Closed -$901K – 5071
2023
Q1 		$901K Buy
+104,819
New +$864K 0.01% 1231

Other funds holding VECT

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Walleye Capital's VECT Position: Q2 2023 in Review

Walleye Capital sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 104,819 shares — an estimated $901K sold.

Walleye Capital first reported a position in VECT in Q1 2023 and held it in 1 quarter. The position peaked at $901K in Q1 2023. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

  • Walleye Capital reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Walleye Capital sold 104,819 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $901K.
  • Walleye Capital first reported a position in VectivBio Holding AG Ordinary Shares in Q1 2023 and held it in 1 quarter.
  • Walleye Capital's VectivBio Holding AG Ordinary Shares position peaked at $901K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.